Amicus Therapeutics (FOLD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2007 | 09-2006 | 06-2006 | |
| Cash Flows From Operating Activities | |||
| Net Income | -9,695 | -28,555 | -16,912 |
| Depreciation Amortization | 297 | 661 | 416 |
| Other Working Capital | -2,164 | 1,043 | 228 |
| Other Operating Activity | 826 | 2,261 | 1,207 |
| Operating Cash Flow | $-10,736 | $-24,590 | $-15,061 |
| Cash Flows From Investing Activities | |||
| Change In Deposits | -5,279 | -6,528 | 10,072 |
| PPE Investments | -204 | -1,587 | -1,008 |
| Investing Cash Flow | $-5,483 | $-8,115 | $9,064 |
| Cash Flows From Financing Activities | |||
| Debt Issued | N/A | 2,199 | 2,008 |
| Debt Repayment | -314 | -542 | -382 |
| Common Stock Issued | 206 | 234 | 205 |
| Other Financing Activity | 24,053 | 63,447 | 27,500 |
| Financing Cash Flow | $23,945 | $65,338 | $29,331 |
| Beginning Cash Position | 12,127 | 6,449 | 6,449 |
| End Cash Position | 19,853 | 39,082 | 29,783 |
| Net Cash Flow | $7,726 | $32,633 | $23,334 |
| Free Cash Flow | |||
| Operating Cash Flow | -10,736 | -24,590 | -15,061 |
| Capital Expenditure | -204 | -1,587 | -1,008 |
| Free Cash Flow | -10,940 | -26,177 | -16,069 |